Bone health in children and youth with Cystic Fibrosis: a systematic review and meta-analysis of matched cohort studies
dc.contributor.author | Ubago-Guisado, E | |
dc.contributor.author | Cavero-Redondo, I | |
dc.contributor.author | Alvarez-Bueno, C | |
dc.contributor.author | Vlachopoulos, D | |
dc.contributor.author | Martínez-Vizcaíno, V | |
dc.contributor.author | Gracia-Marco, L | |
dc.date.accessioned | 2019-09-13T12:02:20Z | |
dc.date.issued | 2019-09-10 | |
dc.description.abstract | Objective To assess the evidence regarding the differences in areal bone mineral density (aBMD) between children and adolescents with cystic fibrosis (CF) compared with their healthy peers, based on data from longitudinal studies. Study design We searched MEDLINE, SPORTDiscus, the Cochrane Library, PEDro (Physiotherapy Evidence Database), and Embase databases. Observational studies addressing the change of aBMD in children with CF and healthy children and adolescents were eligible. The DerSimonian and Laird method was used to compute pooled estimates of effect sizes (ES) and 95% CIs for the change of whole body (WB), lumbar spine (LS), and femoral neck (FN) aBMD. Results Six studies with participants with CF and 26 studies with healthy participants were included in the systematic review and meta-analysis. For the analysis in children with CF, the pooled ES for the change of WB aBMD was 0.29 (95% CI –0.15 to 0.74), for the change of LS aBMD was 0.13 (95% CI –0.16 to 0.41), and for the change of FN aBMD was 0.09 (95% CI –0.39 to 0.57). For the analysis in healthy children, the pooled ES for the change of WB aBMD was 0.37 (95% CI 0.26-0.49), for the change of LS aBMD was 0.13 (95% CI –0.16 to 0.41), and for the change of FN aBMD was 0.52 (95% CI 0.19-0.85). Conclusions aBMD development might not differ between children and adolescents with CF receiving medical care compared with their healthy peers. Further longitudinal studies in a CF population during growth and development are required to confirm our findings. | en_GB |
dc.identifier.citation | Published online 10 September 2019 | en_GB |
dc.identifier.doi | 10.1016/j.jpeds.2019.07.073 | |
dc.identifier.uri | http://hdl.handle.net/10871/38736 | |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier | en_GB |
dc.rights.embargoreason | Under embargo until 10 September 2020 in compliance with publisher policy | en_GB |
dc.rights | © 2019. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dc.subject | adolescence | en_GB |
dc.subject | bone mass | en_GB |
dc.subject | densitometry | en_GB |
dc.subject | pediatric | en_GB |
dc.subject | youth | en_GB |
dc.title | Bone health in children and youth with Cystic Fibrosis: a systematic review and meta-analysis of matched cohort studies | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-09-13T12:02:20Z | |
dc.identifier.issn | 0022-3476 | |
dc.description | This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this record | en_GB |
dc.identifier.journal | Journal of Pediatrics | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dcterms.dateAccepted | 2019-07-29 | |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2019-07-29 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-09-13T11:59:08Z | |
refterms.versionFCD | AM | |
refterms.panel | C | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2019. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/